AGS-30, an andrographolide derivative, suppresses tumor angiogenesis and growth in vitro and in vivo

[Display omitted] Poor bioavailability and limited efficacy are challenges associated with using andrographolide as a therapeutic agent. We recently synthesized AGS-30, a new andrographolide derivative, in our laboratory. In this study we investigated the potential anti-tumor effect of AGS-30 and th...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Biochemical pharmacology 2020-01, Vol.171, p.113694-113694, Article 113694
Hauptverfasser:	Li, Jingjing, Li, Feng, Tang, Fan, Zhang, Jinming, Li, Renkai, Sheng, Dekuan, Lee, Simon Ming-Yuen, Zhou, Guo-Chun, Leung, George Pak-Heng
Format:	Artikel
Sprache:	eng
Schlagworte:	Andrographolide derivative Anti-angiogenic Colon cancer VEGF
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!